量化糖尿病患者对糖尿病视网膜病变监测的偏好与期望
这项网络调查结合离散选择实验与分级配对问题,评估糖尿病患者对糖尿病视网膜病变(DR)监测的偏好与期望如何与预期监测依从行为相关。304名受访者完成调查,结果显示参与者高度重视失明风险降低,但期望DR监测带来的5年失明风险降低幅度远低于其完全依从所需的要求。
要点
- 参与者要求5年失明风险降低3.87个百分点才完全依从年度的53分钟监测及26美元共付费用。
- 受访者期望DR监测仅降低5年失明风险0.71个百分点,低于其依从所需阈值。
- 偏好与监测期望的关联与糖尿病患者监测不依从现象大体一致。
核心结论
- 在糖尿病患者中,使用经过验证的工具测量对DR监测的偏好与期望,为评估患者健康行为提供了机会。
- 偏好与监测期望之间的关联与成人糖尿病患者的监测不依从大体一致,并可能有助于解决DR监测不一致的问题。
研究设计与样本
- 本研究为调查研究,开发并实施了网络调查工具,包含离散选择实验和分级配对问题。
- 调查通过美国国立卫生研究院开发的在线平台ResearchMatch,在自我报告并经医生诊断糖尿病的成人中进行。
- 招募时间为2023年9月15日至2023年10月17日,数据分析时间为2023年10月至2023年12月。
- 调查工具经过认知访谈预测试并为本研究目的进行了验证。
- 共邀请542人,304名受访者满意完成调查;受访者平均(SD)年龄40.5(11.2)岁,169名(56.1%)为女性。
主要发现
- 失明风险降低对参与者有价值。
- 参与者要求5年失明风险降低3.87(95%CI,1.91-5.88)个百分点,才能完全依从年度53分钟监测访视及26美元共付费用。
- 受访者期望DR监测降低5年失明风险0.71(95%CI,0.21-1.28)个百分点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Diabetic retinopathy (DR) is the leading cause of blindness among adults in the US. The US Centers for Disease Control and Prevention recommends annual DR monitoring for all individuals with diabetes, yet monitoring rates remain below 70%. OBJECTIVE: To evaluate how patient preferences and expectations about DR monitoring are associated with expected monitoring adherence behaviors. DESIGN, SETTING, AND PARTICIPANTS: In this survey study, a web-enabled survey instrument was developed and implemented with a discrete-choice experiment to characterize patient preferences for outcomes of DR monitoring and graded-pair questions to quantify patients' expectations about the impact of DR monitoring on blindness risk. The survey was conducted through ResearchMatch, a US National Institutes of Health-developed online platform, among adults with self-reported, physician-diagnosed diabetes. Recruitment occurred between September 15, 2023, and October, 17, 2023, and data analysis occurred between October 2023 and December 2023. Results from the 2 tasks were combined to derive patients' expected monitoring behavior following a recently proposed treatment adherence framework. The survey instrument was pretested in cognitive interviews and validated for the purposes of this study. EXPOSURE: Survey-based discrete-choice experiment and graded-pair questions. MAIN OUTCOMES AND MEASURES: Participants' relative preferences for DR-related blindness risk reductions, monitoring time, and out-of-pocket monitoring costs were quantified, as well as the degree to which participants expected adherence to monitoring to affect the risk of blindness. By combining how much participants valued specific reductions in blindness risk (relative to monitoring costs) and their expected risk reduction through monitoring, the rate at which patients would maximize the benefit of monitoring appointments was assessed. RESULTS: The survey was completed satisfactorily by 304 respondents of 542 individuals invited to participate. Mean (SD) respondent age was 40.5 (11.2) years, and 169 respondents (56.1%) were female. Reductions in blindness risk were valuable to participants. Participants required a 3.87 (95% CI, 1.91-5.88) percentage-point reduction in 5-year blindness risk to be fully adherent to an annual 53-minute monitoring visit with a $26 co-payment, but respondents expected DR monitoring to reduce the 5-year blindness risk by 0.71 (95% CI, 0.21-1.28) percentage points. CONCLUSIONS AND RELEVANCE: In this online survey study among adults with diabetes, measurement of patient preferences and expectations about DR monitoring with properly validated instruments offered an opportunity to assess patient health behaviors. The association between preferences and monitoring expectations was generally consistent with monitoring nonadherence among adults with diabetes and offers insights that may help address inconsistent DR monitoring.
引用
- Gonzalez Sepulveda JM, Yang JC, Mastylak A, et al. Quantifying Patient Preferences and Expectations About Diabetic Retinopathy Monitoring. JAMA Ophthalmol. 2025. PMID: 39699904. doi:10.1001/jamaophthalmol.2024.5365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。